ダンホン注射は,Dihydrotanshinone Iを介してCaMKIIを標的とし,ウイルス性心筋炎における心筋細胞死と炎症を緩和します
Junxia Zhang1,2,3, Chengcheng Zhao4,5, Wenjia Zhang2,3
1Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, State Key Laboratory of Vascular Homeostasis and Remodeling, NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Beijing, 100191, China.
Science China. Life sciences
|September 1, 2025
まとめ
ダンホン注射 (DHI) は,心臓細胞死亡の主要な要因であるCaMKIIを抑制することで,ウイルス性心筋炎を効果的に軽減します. この伝統的な中国医学は ウイルス性心筋炎の治療と 心臓損傷の予防に 有望な効果を示しています
科学分野:
- 心臓病科
- ウイルス学
- 薬理学について
背景:
- ウイルスの感染による心臓の炎症であるウイルス性心筋炎は 限られた治療法により 悪い結果をもたらします
- 心筋細胞死は特徴ですが,そのメカニズムと治療標的は不明です.
- 伝統的な中国医学 (TCM) には,ウイルス性心筋炎の承認された治療法がない.
研究 の 目的:
- ウイルス性心筋炎に対するTCM特許注射の治療の可能性を調査する.
- ダンホン注射 (DHI) の保護効果の背後にあるメカニズムを特定する.
- ウイルス性心筋炎による心臓損傷の軽減におけるDHIの有効性を評価する.
主な方法:
- コクサキウイルスB3 (CVB3) 誘発の心筋細胞死亡に対する有効性について6つのTCM特許注射をスクリーニングした.
- CVB3感染マウスモデルにDHIを投与した.
- 患者サンプルとヒト細胞におけるCa2+/カルモジュリン依存タンパク質キナーゼII (CaMKII) 阻害とリン酸化を評価することによって,DHIのメカニズムを調査した.
主要な成果:
- ダンホン注射 (DHI) は,心筋細胞死亡を in vitro と in vivo で著しく減少させた.
- DHIは,ウイルス性心筋炎のマウスモデルにおける炎症,心臓機能障害,および死亡率を緩和しました.
- DHIは,心筋細胞死亡の重要な要因であるCaMKIIのリン酸化を阻害し,抗炎症効果を示した.
結論:
- CaMKII媒介の心筋細胞死は,ウイルス性心筋炎の進行に中心的です.
- ダンホン注射 (DHI) はウイルス性心筋炎の有望な治療薬です.
- DHIの有効性は,CaMKII抑制と抗炎症性から生じ,新しい治療戦略を提供します.
関連する概念動画
Myocarditis III: Medical Management
15
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
15
Heart Failure Drugs: Inotropic Agents
717
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
717
Myocarditis I: Introduction
28
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
28
Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
Cardiomyopathy V: Interprofessional Care
32
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32
Myocarditis II: Clinical Features and Diagnostic Tests
20
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
20


